New York, NY, May 25, 2017 -- Progyny, the leading fertility benefits company, today announced that it has hired Julie Stadlbauer as Vice President of Business Development. Reporting to Karin Ajmani, President of Healthcare Services, Stadlbauer will be responsible for cultivating and fostering strong relationships with large employers across the country looking to adopt fertility benefits into their offerings to employees.
“Julie is a veteran sales leader for health insurance organizations,” said Ajmani. “Her experience in solving problems for clients and using her entrepreneurial spirit to provide comprehensive offerings that accommodate each organization’s needs will make her a vital asset as Progyny continues to grow.”
Stadlbauer joins Progyny from ConsumerMedical, where she served as Western US Vice President of Employer Solutions. While at ConsumerMedical, she expanded awareness and presence in the western US, helping employers to realize the value of medical decision support and second opinion services. She has also held senior level positions at Bloom Health, CIGNA Healthcare National Accounts, and Health Net.
"It’s an honor to work for an organization with such a powerful mission - to ensure that anyone can have a child when they want,” said Stadlbauer. “I’m eager to help power Progyny’s continued growth as more large employers seek to support their employee’s career and family building goals by implementing differentiating benefits to attract and retain top talent.”
For more information visit, www.Progyny.com.
About Progyny:
Progyny is a leading fertility benefits company that combines service, science, technology and data to provide comprehensive value based fertility solutions for self-insured employers. Progyny’s benefit plans are designed to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. Progyny is privately held and is headquartered in New York, NY, with operations in San Francisco, CA. Please visit www.Progyny.com.
Media Contact: Heather Aponte [email protected] Phone: 646-965-0695


Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex
OpenAI Reportedly Eyes Late-2026 IPO Amid Rising Competition and Massive Funding Needs
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race
Bob Iger Plans Early Exit as Disney Board Prepares CEO Succession Vote
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees
Elon Musk’s SpaceX Explores Merger Options With Tesla or xAI, Reports Say
Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million 



